Dallas-based CTL Medical signed a partnership agreement with G-21 to market G-21's bone cement, kyphoplasty and vertebroplasty technology.
Here are three takeaways:
1. Each of the cement kits comes in the form of a two component system composed of a liquid and powder. The kits offer providers safety assurance and control of mechanical properties during surgery.
2. CTL Medical President and CEO Daniel Chon said, "We intend to begin immediate distribution of the full line of acrylic-based bone cements for widespread procedures necessary for vertebrae consolidation and stabilization."
3. G-21 is an Italian-based biomaterials company that develops long-term implantable medical devices using raw materials.